ADAR1 promotes malignant progenitor reprogramming in chronic myeloid leukemia-Reference-Cited by-同舟云学术

ADAR1 promotes malignant progenitor reprogramming in chronic myeloid leukemia

Published:2012-12-28 Issue:3 Volume:110 Page:1041-1046
ISSN:0027-8424
Container-title:Proceedings of the National Academy of Sciences
language:en
Short-container-title:Proceedings of the National Academy of Sciences

Author:

Jiang Q.,Crews L. A.,Barrett C. L.,Chun H.-J.,Court A. C.,Isquith J. M.,Zipeto M. A.,Goff D. J.,Minden M.,Sadarangani A.,Rusert J. M.,Dao K.-H. T.,Morris S. R.,Goldstein L. S. B.,Marra M. A.,Frazer K. A.,Jamieson C. H. M.

Publisher

Proceedings of the National Academy of Sciences

Subject

Multidisciplinary

Reference50 articles.

1. Stem cell gene expression programs influence clinical outcome in human leukemia

2. The Chronic Myelogenous Leukemia-Specific P210 Protein Is the Product of the bcr / abl Hybrid Gene

3. A New Consistent Chromosomal Abnormality in Chronic Myelogenous Leukaemia identified by Quinacrine Fluorescence and Giemsa Staining

4. Fused transcript of abl and bcr genes in chronic myelogenous leukaemia

Cited by 148 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of RNA modifications in blood development and regeneration;Experimental Hematology;2024-10

2. ADARp150 counteracts whole genome duplication;Nucleic Acids Research;2024-08-27

3. Hepatocyte-macrophage crosstalk via the PGRN-EGFR axis modulates ADAR1-mediated immunity in the liver;Cell Reports;2024-07

4. Non‐m⁶A RNA modifications in haematological malignancies;Clinical and Translational Medicine;2024-06

5. Hallmarks of cancer stemness;Cell Stem Cell;2024-05